1-4 of 4
Wenjing Yu
Close
Sort by
Journal Articles

Cytoreductive Chemotherapy in Induction Therapy Plays a Key Role in the Prognosis of Patients with Low-Risk Acute Promyelocytic Leukemia

Xiaolu Zhu, Feifei Tang, Wenjing Yu, Xiaosu Zhao, Yazhen Qin, Qian Jiang, Xiao Jun Huang, Hao Jiang
Journal: Blood
Blood (2023) 142 (Supplement 1): 1481.
https://doi.org/10.1182/blood-2023-180002
Published: 2023
Journal Articles

Only FLT3-ITD Mutation Did Not Have a Deleterious Effect on Acute Myeloid Leukemia Patients with NPM1 Mutation, but Concomitant with DNMT3A Mutation or a＜3log Reduction of MRD2 Predicted Poor Survival

Wenbing Duan, Jinsong Jia, Jing Wang, Xiaohong Liu, Lizhong Gong, WenJing Yu, Xiaolu Zhu, Zhao Ting, Qian Jiang, Guorui Ruan, Xiaosu Zhao, Yu Wang, Hongxia Shi, Lanping Xu, Xiaohui Zhang, Xiaojun Huang, Hao Jiang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4309.
https://doi.org/10.1182/blood-2023-184769
Published: 2023
Journal Articles

Interferon-α-2b As a Maintenance Therapy Gain a High Rate of MRD Negative Conversion and Improve RFS in Patients with Favorable-Risk Acute Myeloid Leukemia----a Prospective, Single-Arm Study

Xiaohong Liu, Yao Li, Wenjing Yu, Xiaolu Zhu, Jinsong Jia, Lizhong Gong, Xiaosu Zhao, Yingjun Chang, Xiao-Jun Huang, Hao Jiang
Journal: Blood
Blood (2022) 140 (Supplement 1): 3299–3300.
https://doi.org/10.1182/blood-2022-168422
Published: 2022
Journal Articles

Occurrence and Severity of DLI Associated Chronic Gvhd Influence the Clinical Outcomes in Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Wenjing Yu, MD, Xiao-Dong Mo, Xiaohui Zhang, MD, Lan-Ping Xu, MD, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Wei Han, Feng-Rong Wang, Jing-Zhi Wang, Kaiyan Liu, MD PhD, Xiaojun Huang
Journal: Blood
Blood (2018) 132 (Supplement 1): 3412.
https://doi.org/10.1182/blood-2018-99-110670
Published: 2018